filmov
tv
Non-Small Cell Lung Cancer (NSCLC) Immunotherapy: Advancing Hope

Показать описание
SITC presents NSCLC Immunotherapy: Advancing Hope, the newest in a series of videos focusing on immunotherapy for NSCLC patients. This video provides an overview of the building blocks of the immune system and immunotherapy, while also highlighting some of the FDA approved immunotherapy treatments and potential side effects, and the importance of clinical trials.
*This video was produced prior to the October 2016 FDA approvals of 1) TECENTRIQ® (atezolizumab, Genetech, Inc.) in patients whose disease progressed despite treatment with platinum-containing chemotherapy and 2) KEYTRUDA® (pembrolizumab; Merck & Co., Inc.) as first-line therapy in patients whose tumors express high levels of PD-L1 on an FDA-approved test, without certain genetic mutations (EGFR or ALK). As a leader in the field of cancer immunotherapy research and education, SITC will continue to update this video series as additional immunotherapy treatments become available.
*This video was produced prior to the October 2016 FDA approvals of 1) TECENTRIQ® (atezolizumab, Genetech, Inc.) in patients whose disease progressed despite treatment with platinum-containing chemotherapy and 2) KEYTRUDA® (pembrolizumab; Merck & Co., Inc.) as first-line therapy in patients whose tumors express high levels of PD-L1 on an FDA-approved test, without certain genetic mutations (EGFR or ALK). As a leader in the field of cancer immunotherapy research and education, SITC will continue to update this video series as additional immunotherapy treatments become available.
Understanding Non-Small Cell Lung Cancer
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)
Treatment and Management of Non-Small Cell Lung Cancer (NSCLC)
What are the symptoms of non-small cell lung cancer (NSCLC)?
Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/ Targetable Mutations- Dr. Jarushka Naidoo
Non-Small Cell Lung Cancer (NSCLC) Immunotherapy: Advancing Hope
Sanofi – Meet Terri, Living with Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer – An Introduction
Importance of Biomarker in Lung Cancer - 129th Support Group Meeting
Gwen’s Fight with Non-Small Cell Lung Cancer
Understanding Biomarker Testing in Non-Small Cell Lung Cancer
The Basics of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
What is a KRAS mutation in non-small cell lung cancer (NSCLC)?
What is a MET mutation in non-small cell lung cancer (NSCLC)?
What is non-small cell lung cancer (NSCLC)?
What are my options for treatment and management of non-small cell lung cancer (NSCLC)?
Deborah’s Experience with Non-Small Cell Lung Cancer
Which biomarkers exist for Non-Small Cell Lung Cancer (NSCLC)?
Current Management of Stage IIIA Non-Small Cell Lung Cancer: A Changing Paradigm (November 10, 2022)
How is non-small cell lung cancer (NSCLC) diagnosed?
Targeted Therapy in Non-Small Cell Lung Cancer
Differences in Small Cell vs Non-Small Cell Lung Cancer
Dr. Alexander Spira Discusses Advances in Non-Small Cell Lung Cancer (NSCLC)
What's the difference between non-small cell lung cancer & small cell lung cancer? | Norton...
Комментарии